ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease

ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease - ECMOCARD Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039686

Enrollment

500

Registered

2020-03-06

Start date

2020-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Laboratory-confirmed COVID-19 infection by real-time PCR and/or next-generation sequencing 2. Admission to an intensive care unit

Exclusion criteria

Exclusion criteria: 1. Patients treated with mechanical ventilation for other concomitant causes 2. Patients treated with ECMO for other concomitant causes

Design outcomes

Primary

Measure	Time frame
1.Date of ECMO discontinuation 2.Date of invasive mechanical ventilation discontinuation 3.Date of ICU Discharge 4.Date of Hospital Discharge 5.Mortality at 28 days 6.Main cause of death	—

Countries

Japan,Asia(except Japan),Australia,Europe

Contacts

Public ContactKeibun Liu

Saiseikai Utsunomiya Hospital Department of emergency medicine and intensive care unit

keiliu0406@gmail.com028-626-5500

Outcome results